Stability of the activated partial thromboplastin time used to monitor unfractionated heparin

被引：6
|
作者：
Ray, M. [1 ]
机构：
[1] Prince Charles Hosp, Lab Grp, Brisbane, Qld 4032, Australia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2008年 / 6卷 / 10期
关键词：
D O I：
10.1111/j.1538-7836.2008.03101.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1817 / 1819
页数：4
相关论文
共 50 条
  • [1] ACTIVATED PARTIAL THROMBOPLASTIN TIME AS A MONITOR OF HEPARIN THERAPY - WARNING
    MAKARY, AZ
    WATERBURY, L
    JOHNS HOPKINS MEDICAL JOURNAL, 1977, 140 (06): : 311 - 315
  • [2] Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges
    van den Besselaar, AMHP
    Sturk, A
    Reijnierse, GLA
    THROMBOSIS RESEARCH, 2002, 107 (05) : 235 - 240
  • [3] Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations
    Marlar, Richard A.
    Clement, Bernadette
    Gausman, Jana
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 253 - 260
  • [4] Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation
    Thompson, Molly H.
    Wilson, Sylvia H.
    Toussaint, Brittany L.
    Jordan, Cameron L.
    Hayes, Genevieve L.
    McKinzie, Brian P.
    Wolf, Bethany J.
    Field, Larry C.
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 33 : 346 - 350
  • [5] Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin
    Gouin-Thibault, Isabelle
    Samama, Michel M.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (05) : 986 - 987
  • [6] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [7] Activated Partial Thromboplastin Time Elevation After Low-Dose Unfractionated Heparin
    Pirouz, R.
    Smith, P. R.
    Vaynkof, Y.
    Balakrishna, S.
    Chand, R.
    Atluri, S.
    Gerolemou, L.
    Elias, M.
    Mir, S.
    Nishimoto, T.
    Surapaneni, P.
    Jimenez, E.
    O'Neill, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [8] Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa
    Parker, Christine R.
    Kataria, Vivek
    AACN ADVANCED CRITICAL CARE, 2019, 30 (04) : 305 - 312
  • [9] Comparing Activated Partial Thromboplastin Time and Heparin anti-Xa levels to monitor anticoagulant intensity of unfractionated heparin in Extracorporeal Membrane Oxygenation
    Dhillon, E.
    Laffan, M.
    Arachchillage, D. Jayakody
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 138 - 138
  • [10] The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy
    Lapic, Ivana
    Vrancic, Ana Loncar
    Herak, Desiree Coen
    Rogic, Dunja
    BIOCHEMIA MEDICA, 2021, 31 (02) : 021003
12345